This Article Free upon publication Full Text Full Text (PDF) All Versions of this Article: 51/4/991    most recent HYPERTENSIONAHA.107.100735v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Karumanchi, S. A. Articles by Lindheimer, M. D. Search for Related Content PubMed PubMed Citation Articles by Karumanchi, S. A. Articles by Lindheimer, M. D. Pubmed/NCBI databases Medline Plus Health Information High Risk Pregnancy Related Collections Angiogenesis Other hypertension Endothelium/vascular type/nitric oxide Related Article

(Hypertension. 2008;51:991.)
© 2008 American Heart Association, Inc.

Go Red Editorial Commentaries

Preeclampsia Pathogenesis

"Triple A Rating"–Autoantibodies and AntiAngiogenic Factors

S. Ananth Karumanchi; Marshall D. Lindheimer

From the Beth Israel Deaconess Medical Center and Harvard Medical School (S.A.K.), Boston, Mass; and the University of Chicago (M.D.L.), Ill.

Correspondence to S. Ananth Karumanchi, Beth Israel Deaconess Medical Center, 330 Brookline Ave, RW 663, Boston, MA 02215. E-mail sananth@bidmc.harvard.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Preeclampsia, a major killer of mother and fetuses, has traditionally been called the disease of theories, but research these past decades is changing all of that. Early observations related to this disorder were that all of the signs and symptoms typically resolve rapidly after the delivery of the placenta. Thus, it was natural to focus on this organ as the source of the disease. In this respect, 2 antiangiogenic proteins, overproduced in the placenta, that gain access to the maternal circulation have become candidate molecules responsible for phenotypic preeclampsia. One is soluble Fms-like tyrosine kinase-1 (sFlt1), an endogenous inhibitor of vascular endothelial growth factor and placental growth factor signaling that may regulate placental angiogenesis, and the other is soluble endoglin, a circulating coreceptor that may inhibit transforming growth factor-β1 signaling in the vasculature.¹ Maternal blood levels of both of these antiangiogenic proteins are increased in preeclamptic patients compared with those in uncomplicated pregnancies weeks to months before overt signs and symptoms.¹ Adenoviral overexpression of sFlt1 and soluble endoglin in rodents produces preeclampsia-like phenotypes, including severe hypertension, proteinuria, glomerular endotheliosis, and features resembling the HELLP syndrome (hemolysis, elevated liver enzymes, low platelet syndrome) in humans.² The increased risk of preeclampsia in women with multifetal pregnancies, trisomy 13, primiparity, high altitudes, and mirror syndrome may also be explained by alterations in circulating antiangiogenic factors (reviewed in Reference ³).

However, as data supporting a significant role for antiangiogenic factors in producing the maternal syndrome is gradually unfolding (research focused primarily on sFlt1), the . . . [Full Text of this Article]

Related Article:

Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling

Cissy Chenyi Zhou, Shakil Ahmad, Tiejuan Mi, Shahrzad Abbasi, Lingwei Xia, Mary-Clare Day, Susan M. Ramin, Asif Ahmed, Rodney E. Kellems, and Yang Xia
Hypertension 2008 51: 1010-1019. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				J. P. Granger Vascular Endothelial Growth Factor Inhibitors and Hypertension: A Central Role for the Kidney and Endothelial Factors? Hypertension, September 1, 2009; 54(3): 465 - 467. [Full Text] [PDF]

				S. A. Bainbridge, J. M. Roberts, F. von Versen-Hoynck, J. Koch, L. Edmunds, and C. A. Hubel Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers Am J Physiol Cell Physiol, August 1, 2009; 297(2): C440 - C450. [Abstract] [Full Text] [PDF]

				A. Wang, S. Rana, and S. A. Karumanchi Preeclampsia: The Role of Angiogenic Factors in Its Pathogenesis Physiology, June 1, 2009; 24(3): 147 - 158. [Abstract] [Full Text] [PDF]